nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Metaraminol—ADRA1A—polycystic ovary syndrome	0.0199	0.31	CrCbGaD
Tapentadol—Phenylephrine—ADRA1D—polycystic ovary syndrome	0.0182	0.284	CrCbGaD
Tapentadol—Phenylephrine—ADRA1B—polycystic ovary syndrome	0.0156	0.242	CrCbGaD
Tapentadol—Phenylephrine—ADRA1A—polycystic ovary syndrome	0.0105	0.163	CrCbGaD
Tapentadol—Lethargy—Metformin—polycystic ovary syndrome	0.00879	0.0383	CcSEcCtD
Tapentadol—Breast disorder—Metformin—polycystic ovary syndrome	0.00778	0.0339	CcSEcCtD
Tapentadol—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0077	0.0336	CcSEcCtD
Tapentadol—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00713	0.0311	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00692	0.0302	CcSEcCtD
Tapentadol—Infestation NOS—Metformin—polycystic ovary syndrome	0.00663	0.0289	CcSEcCtD
Tapentadol—Infestation—Metformin—polycystic ovary syndrome	0.00663	0.0289	CcSEcCtD
Tapentadol—Bradycardia—Metformin—polycystic ovary syndrome	0.00606	0.0264	CcSEcCtD
Tapentadol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00593	0.0258	CcSEcCtD
Tapentadol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00585	0.0255	CcSEcCtD
Tapentadol—Eye disorder—Metformin—polycystic ovary syndrome	0.00557	0.0243	CcSEcCtD
Tapentadol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00553	0.0241	CcSEcCtD
Tapentadol—Angiopathy—Metformin—polycystic ovary syndrome	0.0054	0.0236	CcSEcCtD
Tapentadol—Immune system disorder—Metformin—polycystic ovary syndrome	0.00538	0.0235	CcSEcCtD
Tapentadol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00537	0.0234	CcSEcCtD
Tapentadol—Chills—Metformin—polycystic ovary syndrome	0.00534	0.0233	CcSEcCtD
Tapentadol—Malnutrition—Metformin—polycystic ovary syndrome	0.00518	0.0226	CcSEcCtD
Tapentadol—Vision blurred—Metformin—polycystic ovary syndrome	0.00489	0.0213	CcSEcCtD
Tapentadol—Tremor—Metformin—polycystic ovary syndrome	0.00486	0.0212	CcSEcCtD
Tapentadol—Syncope—Metformin—polycystic ovary syndrome	0.00465	0.0203	CcSEcCtD
Tapentadol—Palpitations—Metformin—polycystic ovary syndrome	0.00458	0.02	CcSEcCtD
Tapentadol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00456	0.0199	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00438	0.0191	CcSEcCtD
Tapentadol—Oedema—Metformin—polycystic ovary syndrome	0.00423	0.0185	CcSEcCtD
Tapentadol—Infection—Metformin—polycystic ovary syndrome	0.0042	0.0183	CcSEcCtD
Tapentadol—Shock—Metformin—polycystic ovary syndrome	0.00416	0.0182	CcSEcCtD
Tapentadol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00415	0.0181	CcSEcCtD
Tapentadol—Skin disorder—Metformin—polycystic ovary syndrome	0.00411	0.0179	CcSEcCtD
Tapentadol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00409	0.0178	CcSEcCtD
Tapentadol—Hypotension—Metformin—polycystic ovary syndrome	0.00395	0.0172	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00386	0.0168	CcSEcCtD
Tapentadol—Paraesthesia—Metformin—polycystic ovary syndrome	0.0038	0.0166	CcSEcCtD
Tapentadol—Dyspnoea—Metformin—polycystic ovary syndrome	0.00377	0.0165	CcSEcCtD
Tapentadol—Somnolence—Metformin—polycystic ovary syndrome	0.00376	0.0164	CcSEcCtD
Tapentadol—Dyspepsia—Metformin—polycystic ovary syndrome	0.00372	0.0162	CcSEcCtD
Tapentadol—Decreased appetite—Metformin—polycystic ovary syndrome	0.00368	0.016	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00365	0.0159	CcSEcCtD
Tapentadol—Fatigue—Metformin—polycystic ovary syndrome	0.00365	0.0159	CcSEcCtD
Tapentadol—Constipation—Metformin—polycystic ovary syndrome	0.00362	0.0158	CcSEcCtD
Tapentadol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00349	0.0152	CcSEcCtD
Tapentadol—Urticaria—Metformin—polycystic ovary syndrome	0.00336	0.0147	CcSEcCtD
Tapentadol—Asthenia—Metformin—polycystic ovary syndrome	0.00304	0.0132	CcSEcCtD
Tapentadol—Pruritus—Metformin—polycystic ovary syndrome	0.00299	0.0131	CcSEcCtD
Tapentadol—Diarrhoea—Metformin—polycystic ovary syndrome	0.0029	0.0126	CcSEcCtD
Tapentadol—Dizziness—Metformin—polycystic ovary syndrome	0.0028	0.0122	CcSEcCtD
Tapentadol—Vomiting—Metformin—polycystic ovary syndrome	0.00269	0.0117	CcSEcCtD
Tapentadol—Rash—Metformin—polycystic ovary syndrome	0.00267	0.0116	CcSEcCtD
Tapentadol—Dermatitis—Metformin—polycystic ovary syndrome	0.00267	0.0116	CcSEcCtD
Tapentadol—Headache—Metformin—polycystic ovary syndrome	0.00265	0.0116	CcSEcCtD
Tapentadol—Nausea—Metformin—polycystic ovary syndrome	0.00251	0.011	CcSEcCtD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000253	0.000359	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000252	0.000357	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00025	0.000353	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKR1C3—polycystic ovary syndrome	0.00025	0.000353	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000249	0.000352	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000246	0.000349	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000246	0.000348	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000246	0.000348	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000242	0.000343	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000241	0.000341	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000241	0.000341	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.00024	0.00034	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000239	0.000339	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000239	0.000338	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000239	0.000338	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000238	0.000337	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000236	0.000335	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000235	0.000333	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—RRM2—polycystic ovary syndrome	0.000235	0.000332	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000235	0.000332	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000233	0.00033	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000233	0.00033	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000232	0.000328	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000231	0.000327	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00023	0.000326	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000228	0.000322	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000227	0.000321	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	0.000226	0.00032	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000224	0.000317	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000223	0.000315	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000223	0.000315	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000222	0.000315	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00022	0.000312	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000219	0.00031	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000218	0.000309	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000218	0.000308	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	0.000217	0.000308	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000216	0.000306	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000216	0.000306	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000215	0.000305	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000215	0.000304	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000215	0.000304	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000214	0.000303	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000213	0.000302	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000213	0.000302	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TH—polycystic ovary syndrome	0.000213	0.000301	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000211	0.000298	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00021	0.000298	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000207	0.000293	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000207	0.000292	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000206	0.000292	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000205	0.00029	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000205	0.00029	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000203	0.000288	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000203	0.000287	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000203	0.000287	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000203	0.000287	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000203	0.000287	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000203	0.000287	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.0002	0.000283	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	0.0002	0.000283	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000198	0.000281	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000196	0.000278	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000195	0.000276	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000195	0.000276	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000195	0.000276	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000194	0.000275	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000193	0.000274	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000193	0.000273	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000192	0.000272	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000191	0.000271	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000189	0.000267	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000188	0.000266	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000186	0.000264	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000185	0.000262	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000183	0.000258	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000178	0.000253	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000178	0.000252	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000178	0.000252	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000177	0.000251	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000177	0.00025	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000177	0.00025	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000174	0.000247	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	0.000174	0.000246	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.000173	0.000244	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000172	0.000243	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000171	0.000242	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00017	0.000241	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00017	0.000241	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00017	0.00024	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000169	0.000239	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000168	0.000238	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000168	0.000237	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000167	0.000236	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000166	0.000235	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000165	0.000234	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	0.000165	0.000234	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000165	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000163	0.000231	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000163	0.00023	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000162	0.000229	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000161	0.000228	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000158	0.000224	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000157	0.000222	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000156	0.000221	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000156	0.00022	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000155	0.00022	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000155	0.00022	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000155	0.000219	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000154	0.000218	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000152	0.000215	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.00015	0.000213	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00015	0.000213	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00015	0.000213	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000149	0.000212	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000148	0.00021	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000147	0.000208	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	0.000146	0.000207	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000145	0.000206	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000145	0.000205	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000143	0.000203	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000143	0.000203	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000142	0.000201	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	0.000141	0.0002	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00014	0.000198	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000139	0.000197	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000138	0.000196	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000137	0.000194	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000136	0.000193	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000134	0.00019	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	0.000134	0.00019	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000132	0.000187	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000132	0.000187	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000131	0.000186	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000131	0.000186	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00013	0.000184	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000129	0.000183	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000128	0.000181	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000128	0.000181	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.00018	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000126	0.000179	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000125	0.000176	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000124	0.000176	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000124	0.000175	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000123	0.000173	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000122	0.000173	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.00012	0.00017	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000119	0.000169	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	0.000119	0.000168	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	0.000118	0.000168	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000118	0.000166	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	0.000117	0.000165	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000117	0.000165	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—INS—polycystic ovary syndrome	0.000116	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000115	0.000163	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.000114	0.000161	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000114	0.000161	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000113	0.00016	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.00011	0.000156	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00011	0.000155	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000109	0.000155	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000109	0.000154	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000108	0.000153	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000107	0.000151	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.000106	0.000151	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000105	0.000148	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000105	0.000148	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000104	0.000147	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000104	0.000147	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000102	0.000145	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000102	0.000144	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000144	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000101	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000101	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000101	0.000143	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000142	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.0001	0.000142	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	9.78e-05	0.000138	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	9.7e-05	0.000137	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	9.63e-05	0.000136	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.57e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.54e-05	0.000135	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.53e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	9.49e-05	0.000134	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—INS—polycystic ovary syndrome	9.44e-05	0.000134	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	9.4e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.38e-05	0.000133	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.32e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	9.28e-05	0.000131	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.26e-05	0.000131	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.23e-05	0.000131	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.2e-05	0.00013	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	9.19e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.14e-05	0.000129	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	9.13e-05	0.000129	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	9.04e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.84e-05	0.000125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.83e-05	0.000125	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	8.77e-05	0.000124	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	8.69e-05	0.000123	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	8.63e-05	0.000122	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.55e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.39e-05	0.000119	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TH—polycystic ovary syndrome	8.12e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.06e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	7.9e-05	0.000112	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	7.76e-05	0.00011	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	7.72e-05	0.000109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.71e-05	0.000109	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.47e-05	0.000106	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	7.47e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.46e-05	0.000106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.42e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.4e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	7.26e-05	0.000103	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.2e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.09e-05	0.0001	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	6.83e-05	9.67e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	6.77e-05	9.58e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.76e-05	9.56e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.63e-05	9.38e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.58e-05	9.32e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.31e-05	8.94e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.1e-05	8.63e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.04e-05	8.55e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.98e-05	8.47e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.81e-05	8.22e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.77e-05	8.17e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.76e-05	8.15e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.71e-05	8.08e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.58e-05	7.9e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	5.5e-05	7.79e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.46e-05	7.72e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.13e-05	7.26e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.09e-05	7.2e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.88e-05	6.9e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	4.55e-05	6.44e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.52e-05	6.4e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.46e-05	6.32e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.44e-05	6.28e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.16e-05	5.89e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.13e-05	5.84e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.1e-05	5.81e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.08e-05	5.78e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.07e-05	5.76e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.05e-05	5.73e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	3.99e-05	5.65e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.37e-05	4.77e-05	CbGpPWpGaD
